Skip to main content
Clinical Trials/CTRI/2023/06/054025
CTRI/2023/06/054025Not yet recruitingPhase 2/3

Efficacy of an Ayurvedic Intervention on Chronic Suppurative Otitis Media

Banaras Hindu University1 site in 1 country200 target enrollmentStarted: June 30, 2023Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Enrollment
200
Locations
1
Primary Endpoint
Discharge quality and quantity

Study Overview

Brief Summary

The patient diagnosed with Chronic suppurative otitis media fulfilling inclusion and exclusion criteria attending OPD Shalakya tantra and ENT OPD, S.S.Hospital ,IMS, BHU will be assigned into study group and trial group stratified block randomised 6 patient in 1 block with strata of discharge mild, moderate and severe.Each group comprises 100 patients. Study group will receive Sarivadi vati (500mg) 2 tablet bd,after food upto 1 month and dry mopping and Karnadhoopana yoga 5-10 gm for 7 days and control group will receive aural toileting with vinegar (1ml) and normal saline(1ml) for 5 days , local antibiotic ciprofloxacin 2 drops bd  for 5 days. The study will be interventional, comparative RCT. The patients will be assessed based on subjective and objective parameters and follow up for consecutive 2 months in an interval of one month. Subjective parameters will be assessed according to scores -Otorrhea/Ear discharge -quality/quantity, Hearing loss,Tinnitus, Just before commencing treatment, after treatment and during follow up. Objective parameters include Perforation of Tympanic membrane, Pure Tone Audiometry and culture sensitivity test, assessed on before treatment and after treatment. The data collected will be analysed statistically by using appropriate test.

Study Design

Study Type
Interventional
Allocation
Stratified block randomization
Masking
Open Label

Eligibility Criteria

Ages
10.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients Suffering from Safe or Tubo-Tympanic Chronic Suppurative Otitis Media without complications Chronicity of the CSOM more than 3 months Patients ready to sign informed consent form.

Exclusion Criteria

  • Patients Suffering from Unsafe or Attico-antral Chronic Suppurative Otitis Media Chronicity of CSOM less than 3 months CSOM with systemic complications CSOM with serosanguinous discharge CSOM with Sensori-nueral and mixed hearing loss.

Outcomes

Primary Outcomes

Discharge quality and quantity

Time Frame: Day 0,Day7, Day15,Day30, Day45, Day 60

Secondary Outcomes

  • Changes in Perforation of TM,(Culture and Sensitivity and)

Investigators

Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials